Squaric Acid Treatment CAS 2892-51-5

A fully conjugated tetracyclic skeleton with four carbon electrons uniformly delocalized, easily dissociated hydroxyl groups to release hydrogen ions, in a strongly acidic environment; Sodium formate (dibutyl formate) has improved lipid solubility and can penetrate the stratum corneum of the skin, making it the standard dosage form for topical treatment; Free oxalic acid has strong water solubility and weak penetration of keratin, and is rarely used directly for skin application.
Di-n-butyl formate (SDB): a light yellow oily liquid, fat soluble, with strong skin penetration. A clinical standard treatment solution is a 0.5% -2% ethanol solution;

After contact with the dermis layer, dibutyl formate acts as a hapten to bind to the protein of skin keratinocytes, forming a complete antigen complex and initiating a local immune cascade reaction:
Recruit dendritic cells (DCs) to mature and activate, migrate to local lymph nodes, activate CD8 ⁺ cytotoxic T cells, and Th1 type immune responses;
Reversing local Th2 dominant immune suppression in vitiligo lesions, inhibiting melanocyte autoantibody attack, repairing melanocyte survival, proliferation, and melanin synthesis;

In alopecia areata lesions, targeted clearance of self reactive T lymphocytes attacking hair follicles, release of hair follicle immune dormancy, and restart of hair growth cycle;
Localized induction of mild controllable contact dermatitis (redness, itching, scabbing), artificial establishment of moderate inflammatory microenvironment, stimulation of epidermal stem cell, melanocyte, and hair follicle stem cell regeneration;
The entire process is limited to the application area, with minimal systemic absorption into the bloodstream. There are no systemic side effects such as elevated blood sugar, osteoporosis, skin atrophy, or capillary dilation caused by adrenal cortex hormones. It should be used with caution and control during childhood and pregnancy.

Pre treatment: Clean the affected area with clean water, completely dry it, and apply Vaseline for isolation and protection on healthy skin to prevent normal skin irritation and redness;
Medication application: Apply a thin layer of 0.5% -1% dibutyl citrate ethanol solution on a cotton swab, limited to precise spot application on the lesion, and prohibit large area thick application;

Mechanism: Specific clearance of self attacking T cells around hair follicles, restoration of hair follicle papilla blood supply and proliferation signals; Hormones only broad-spectrum inhibit inflammation and cannot selectively clear pathogenic T cells.
Complete baldness/generalized baldness (complete baldness of the scalp, shedding of eyebrows, eyelashes, and body hair): Oral administration of the hormone system has significant side effects, and local acid therapy is the safe first choice; Take turns applying medication in different regions to avoid severe dermatitis in the entire area. The overall hair regeneration rate at 6 months is 58%, which is significantly better than that of calcineurin inhibitors (tacrolimus has an effective rate of 39%); 

Children over 4 years old can reduce their dosage to a low concentration of 0.25% without interfering with their growth and development.
Refractory hormone resistant alopecia areata: For patients with long-term ineffective topical/oral steroids, switching to acid therapy results in a regeneration response rate of 65% within 4 months, making it the gold standard for second-line salvage treatment in European and American dermatology guidelines; No hormone dependence, no skin thinning, no excessive hair rebound.
Clinical comparative advantages: Long term use of hormones can cause vascular atrophy around hair follicles, while acid therapy can thicken local dermal microcirculation. Long term use of healthy scalp texture can maintain stability without rapid relapse after discontinuation of medication.

Vitiligo autoimmune attacks epidermal melanocytes, causing depigmentation of white patches. Acid therapy is suitable for stable and progressive mild to moderate white patches, and can be used on the limbs, face, and trunk.
Localized vitiligo in stable phase (area<10% body surface area): 1% dibutyl citrate dot coating, combined with narrow-band ultraviolet NB-UVB phototherapy for synergistic enhancement; Induction of Th1 immune balance by oxalic acid, stimulation of melanocyte division by UVB, combined regimen achieved an 81% pigment recoloration rate, while hormone alone achieved a 59% recoloration rate; Uniform color reproduction, without local pigment unevenness or capillary dilation caused by hormones.

Rapid diffusion of white patches during the progression phase: Low concentration of 0.25% slowly induces mild immunity, inhibits the spread of autoantibodies to attack new melanocytes, and prevents the expansion of white patches; Oral steroids are only suitable for rapid outbreak and large-scale progression, and there is no risk of systemic immune suppression in the local area. They are suitable for long-term maintenance of anti spread.
Limb refractory vitiligo (white spots on fingers and toes, extremely difficult to color with conventional drugs): Squaric Acid Treatment combined with 308 excimer laser increased the limb color restoration rate to 47% after 6 months, compared to only 26% with a single laser; Fang acid opens the dense keratin barrier at the extremities, enhancing the efficiency of laser activation of deep melanocyte stem cells.

Mucosal vitiligo (lip and external genital mucosa vitiligo): Dilute 0.25% gently and apply thinly. The mucosal tolerance is higher than that of potent hormones, and it will not cause mucosal atrophy, dryness, or rupture; During the middle and late stages of pregnancy, small area use can be monitored by a physician, and systemic absorption can be ignored.
Taboo tip: During the progression stage, extensive white patches should not be applied to the entire area to avoid triggering homomorphic reactions and transient expansion of white patches due to widespread and severe contact dermatitis.

Traditional cryotherapy, laser therapy, and salicylic acid treatments only physically destroy the warts, failing to eliminate latent HPV virus in the epidermis, resulting in a recurrence rate as high as 40%–60%. Dibutyl squaric acid therapy, through local immune activation, clears both surface and latent viruses, significantly reducing recurrence.

For plantar warts and common warts: 1% dibutyl squaric acid is precisely applied to the warts twice a week, resulting in warts drying and falling off in 4–6 weeks. After immune activation, surrounding latent HPV is cleared, reducing the recurrence rate to 11%. Compared to salicylic acid corrosion, it causes no severe pain, no deep keratin ulcers, and leaves no permanent scars.

For genital warts (adjunctive treatment): After laser and cryotherapy remove large warts, low-concentration dibutyl squaric acid is applied to residual small subclinical lesions to activate local immunity and clear latent viruses, reducing the postoperative recurrence rate by 52%. It is a safer alternative to podophyllotoxin (teratogenic and highly corrosive) during the preconception and breastfeeding periods.

Subungual warts and periungual warts: The nail bed is fragile and cannot withstand freezing corrosion. Applying a small amount of squaric acid to the periungual lesions can slowly dissolve the warts, protect the nail matrix from damage, and prevent the normal growth of the nail from being disrupted.

Excessive proliferation of fibroblasts and disorderly accumulation of collagen in scar tissue, accompanied by local chronic low-grade inflammation; Fang acid induces controllable mild inflammation, reshapes the arrangement of dermal collagen, and inhibits abnormal proliferation of fibroblasts.
Small scar tissue (postoperative hypertrophic scars on the chest, shoulder, and earlobe): Apply 0.5% oxalic acid solution thinly twice a week. 

After 3 months, the scar thickness decreases by 35% and itching and pain are significantly relieved; Paired with silicone adhesive for dual synergy, it is superior to single hormone scar injection (hormone injection is prone to local skin depression and pigmentation abnormalities).
Postoperative hypertrophic surgical scars: After complete healing of the suture wound, low concentration oxalic acid maintenance is initiated to reduce excessive collagen deposition, improve scar flatness, and rapidly reduce red congestion; Not interfering with the process of epidermal healing.

Hypertrophic chronic eczema, recurrent contact dermatitis patches, and long-term steroid application can easily cause skin barrier breakdown; Intermittent acid therapy is used for small area hypertrophic lesions: low concentration medication is applied every 4 days to induce transient inflammation and restart skin barrier repair. Th2 imbalance is corrected, and the frequency of eczema itching attacks decreases by 60%; Not the first choice for treating large areas of eczema throughout the body, limited to local targeted therapy for isolated hypertrophic and stubborn plaques.

After large-scale epidermal transplantation and scar skin grafting for vitiligo, a small amount of white spot recurrence area is rejected at the edge. Di-n-butyl formate is applied around the transplanted skin to regulate the local immune microenvironment, reduce the rejection attack of host T cells on transplanted melanocytes, improve the survival rate of pigment in the transplanted skin, and reduce the probability of white spot recurrence after transplantation.